JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB28283

Anti-Cyclin D3/CCND3 antibody [DCS2.2]

Be the first to review this product! Submit a review

|

(38 Publications)

Mouse Monoclonal Cyclin D3/CCND3 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 38 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human G1/S-specific cyclin-D3.

View Alternative Names

G1/S-specific cyclin-D3, CCND3

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)

ab28283 (4μg/ml) staining Cyclin D3/CCND3 in human pancreas, using an automated system (DAKO Autostainer Plus). Using this protocol there is strong nuclear staining.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

Flow Cytometry - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)

Overlay histogram showing HeLa cells stained with ab28283 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab28283, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was a goat anti-mouse DyLight® 488 (IgG; H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)
  • WB

Unknown

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)

All lanes:

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (ab28283) at 1 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 10 µg

Lane 2:

Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg

Lane 3:

K562 (Human erythromyeloblastoid leukemia cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 33 kDa

Observed band size: 35 kDa,75 kDa

true

Exposure time: 8min

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)
  • WB

Lab

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)

Lanes 1-4 : Merged signal (red and green). Green - ab28283 observed at 35 kDa. Red - loading control ab52901.

ab28283 Anti-Cyclin D3/CCND3 antibody [DCS2.2] was shown to specifically react with Cyclin in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264931 (knockout cell lysate ab257876) was used. Wild-type and Cyclin knockout samples were subjected to SDS-PAGE. ab28283 and Anti-beta Tubulin [EP1331Y] - Microtubule Marker (ab52901) were incubated at room temperature for 2.5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (ab216777) and Goat anti-Mouse IgG H&L (IRDye® 800CW) preadsorbed (ab216772) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (ab28283) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

CCND3 knockout HeLa cell lysate at 20 µg

Lane 3:

Jurkat cell lysate at 20 µg

Lane 4:

HEK-293 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-680rd-preadsorbed-ab216777'>ab216777</a>) at 1/10000 dilution

Predicted band size: 33 kDa

Observed band size: 35 kDa

false

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)
  • WB

Lab

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (AB28283)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : Cyclin D3/CCND3 (KO) knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HEK293 whole cell lysate (20 μg)
Lane 4 : Jurkat whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab28283 observed at 33 kDa. Red - loading control, ab176560, observed at 50 kDa.

ab28283 was shown to specifically recognize CCND3 in wild-type HAP1 cells along with additional cross reactive bands. No bands was observed when CCND3 knockout samples were uexamined. Wild-type and CCND3 knockout samples were subjected to SDS-PAGE. ab28283 and ab176560 (Rabbit anti alpha Tubulin loading control) were incubated overnight at 4°C at 1 ug/ml and 1/10,000 dilution respectively. Blots were developed with Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed ab216772 and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed ab216777 secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Cyclin D3/CCND3 antibody [DCS2.2] (ab28283)

Predicted band size: 33 kDa

Observed band size: 33 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

DCS2.2

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, IHC-P, WB

applications

Immunogen

Recombinant Full Length Protein corresponding to Human G1/S-specific cyclin-D3.

P30281

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "FlowCyt-species-checked": "predicted", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A/G
Storage buffer
Preservative: 0.08% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition (PubMed : 8114739). Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase (PubMed : 8114739). Hypophosphorylates RB1 in early G(1) phase (PubMed : 8114739). Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals (PubMed : 8114739). Component of the ternary complex, cyclin D3/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex (PubMed : 16782892). Shows transcriptional coactivator activity with ATF5 independently of CDK4 (PubMed : 15358120).
See full target information G1/S-specific cyclin-D3

Publications (38)

Recent publications for all applications. Explore the full list and refine your search

Molecular carcinogenesis 63:1907-1921 PubMed38923703

2024

AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zifeng Deng,Liangding Dou,Zhen Luo,Rong Liu,Jinwen Zhang,Jing Wang,Dai Wang,DongBei Guo,Ran An,Youliang Yao,Guihua Qiu,Yongxing Zhang

Cell reports 42:113564 PubMed38100350

2023

Heterogeneity and transcriptional drivers of triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Bojana Jovanović,Daniel Temko,Laura E Stevens,Marco Seehawer,Anne Fassl,Katherine Murphy,Jayati Anand,Kodie Garza,Anushree Gulvady,Xintao Qiu,Nicholas W Harper,Veerle W Daniels,Huang Xiao-Yun,Jennifer Y Ge,Maša Alečković,Jason Pyrdol,Kunihiko Hinohara,Shawn B Egri,Malvina Papanastasiou,Raga Vadhi,Alba Font-Tello,Robert Witwicki,Guillermo Peluffo,Anne Trinh,Shaokun Shu,Benedetto Diciaccio,Muhammad B Ekram,Ashim Subedee,Zachary T Herbert,Kai W Wucherpfennig,Anthony G Letai,Jacob D Jaffe,Piotr Sicinski,Myles Brown,Deborah Dillon,Henry W Long,Franziska Michor,Kornelia Polyak

Disease models & mechanisms 16: PubMed37577930

2023

Disrupting Hedgehog signaling in melanocytes by SUFU knockout leads to ocular melanocytosis and anterior segment malformation.

Applications

Unspecified application

Species

Unspecified reactive species

Weizhuo Wang,Feiyang Li,Jing Wang,Zuimeng Liu,Meiyu Tian,Zhenhang Wang,Huirong Li,Jia Qu,Yu Chen,Ling Hou

Food science & nutrition 11:493-503 PubMed36655066

2023

Alcohol extracts of Chinese bayberry branch induce S-phase arrest and apoptosis in HepG2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yuanyuan Zheng,Zheping Yu,Yougui Li,Shi Zhong,Yuqing Sun,Li Sun,Xiliang Zheng,Xingjiang Qi,Shuwen Zhang

Cancer research 83:264-284 PubMed36409824

2022

JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.

Applications

Unspecified application

Species

Unspecified reactive species

Laura E Stevens,Guillermo Peluffo,Xintao Qiu,Daniel Temko,Anne Fassl,Zheqi Li,Anne Trinh,Marco Seehawer,Bojana Jovanović,Maša Alečković,Callahan M Wilde,Renee C Geck,Shaokun Shu,Natalie L Kingston,Nicholas W Harper,Vanessa Almendro,Alanna L Pyke,Shawn B Egri,Malvina Papanastasiou,Kendell Clement,Ningxuan Zhou,Sarah Walker,Jacqueline Salas,So Yeon Park,David A Frank,Alexander Meissner,Jacob D Jaffe,Piotr Sicinski,Alex Toker,Franziska Michor,Henry W Long,Beth A Overmoyer,Kornelia Polyak

Journal of clinical laboratory analysis 36:e24633 PubMed36085568

2022

Upregulation of KIF18B facilitates malignant phenotype of esophageal squamous cell carcinoma by activating CDCA8/mTORC1 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jiangliu Xie,Bo Wang,Wenjie Luo,Chen Li,Xunchao Jia

International journal of molecular sciences 23: PubMed35897737

2022

The Pt(-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Zana Besser Silconi,Vesna Rosic,Sasa Benazic,Gordana Radosavljevic,Marina Mijajlovic,Jelena Pantic,Zoran R Ratkovic,Gordana Radic,Aleksandar Arsenijevic,Marija Milovanovic,Nebojsa Arsenijevic,Jelena Milovanovic

Communications biology 5:598 PubMed35710947

2022

MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chiara Turco,Gabriella Esposito,Alessia Iaiza,Frauke Goeman,Anna Benedetti,Enzo Gallo,Theodora Daralioti,Letizia Perracchio,Andrea Sacconi,Patrizia Pasanisi,Paola Muti,Claudio Pulito,Sabrina Strano,Zaira Ianniello,Alessandro Fatica,Mattia Forcato,Francesco Fazi,Giovanni Blandino,Giulia Fontemaggi

Oncology letters 22:628 PubMed34267820

2021

Aqueous extracts of induce S-phase arrest and apoptosis in human melanoma A375 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Taihen Yu,Shi Zhong,Yuqing Sun,Haiyan Sun,Weiguo Chen,Yougui Li,Jianxun Zhu,Longxi Lu,Jinxi Huo

Nutrients 13: PubMed33807148

2021

Shikonin Derivatives from Decrease Expression of Phosphorylated STAT3 in Leukemia Cells and Exert Antitumor Activity.

Applications

Unspecified application

Species

Unspecified reactive species

Zeljko Todorovic,Jelena Milovanovic,Dragana Arsenijevic,Nenad Vukovic,Milena Vukic,Aleksandar Arsenijevic,Predrag Djurdjevic,Marija Milovanovic,Nebojsa Arsenijevic
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com